We observe that PHLPP2 also targets phospho-AMPK in solid tumor-derived cancer lines (Fig. 1F), although differences in the impact of PHLPP2 loss on their responses to glucose limitation (Fig. S3) suggest different roles for AMPK in the cell lines. This evidence concerns the gene PHLPP2 and cancer.